BEZETABART
UNII M00ALT7DTN

Substance Identification & Data

This profile provides standardized clinical and technical data for Bezetabart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) M00ALT7DTN.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2763746-69-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
M00ALT7DTN
CAS Registry Number
2763746-69-4
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
BEZETABART
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C203043
National Cancer Institute reference terminology for clinical and research data.
INN ID
12653
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Bezetabart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BEZETABART

Common Names & Synonyms

BEZETABART [INN]
GAMMA1 HEAVY CHAIN (1-454) (VH (HOMO SAPIENS IGHV3-30-5*03 (95.9%) -(IGHD) -IGHJ6*01 (93.8%), CDR-IMGT (8.8.16) (27-34.52-59.98-113)) (1-124) -HOMO SAPIENS IGHG1*03V, G1M3>G1M17, NG1M1 CH1 K120, CH3 E12, M14 (CH1 R120>K (221) (125-222), HINGE 1-15 (223-237), CH2 (238-347), CH3 E12 (363), M14 (365), F85.2>F (PAMF) (411) (348-452), CHS (453-454)) (125-454)), (227-215')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-215') (V-KAPPA (HOMO SAPIENS IGKV1-12*01 (92.6%) -IGKJ4*01 (100%), CDR-IMGT (6.3.9) (28'-33'.51'-53'.90'-98')) (1'-108') -HOMO SAPIENS IGKC*01 (100%), KM3, A45.1 (154'), V101 (192') (109'-215')); DIMER (233-233'':236-236'')-BISDISULFIDE, PRODUCED BY A CELL-FREE PROTEIN EXPRESSION SYSTEM BASED ON ESCHERICHIA COLI LYSATE, NON-GLYCOSYLATED, SUBSTITUTED AT C-4 OF THE TWO L -PHENYLALANYL RESIDUES 411 AND 411'' WITH AZIDOMETHYL (TAZIDE) GROUPS
IMMUNOGLOBULIN G1 (411-(4-AZIDOMETHYL-L-PHENYLALANINE)), ANTI-(HUMAN CD74 ANTIGEN) (HUMAN MONOCLONAL SP7219 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL SP7219 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CD74 (MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II INVARIANT CHAIN)), MONOCLONAL ANTIBODY, MODIFIED AT TWO SPECIFIC POSITIONS WITH REACTIVE 4-(AZIDOMETHYL)-L -PHENYLALANINE RESIDUES

Technical Codes

SP7219
SP-7219

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus